BPC-157, a synthetic pentadecapeptide derived from human gastric juice, has been studied extensively in rodent models for tissue repair and anti-inflammatory effects.
Body Protection Compound-157 (BPC-157) is a synthetic 15-amino acid sequence derived from a larger gastric protein found in human gastric juice. First identified and studied by researchers at the University of Zagreb, BPC-157 has been examined in numerous rodent studies for its potential effects on tissue repair, inflammation modulation, and organ protection.
BPC-157 was initially studied in the context of gastrointestinal protection. In rodent models, administration has been associated with accelerated healing of gastric ulcers, reduction in intestinal permeability under stress conditions, and protection against NSAID-induced gut damage. Researchers have proposed that these effects are mediated in part through modulation of nitric oxide (NO) production and vascular endothelial growth factor (VEGF) signaling.
Unlike many peptides, BPC-157 exhibits stability in the presence of human gastric juice, which has made it a subject of interest for oral administration routes in animal research. Its apparent resistance to enzymatic degradation under acidic conditions is an active area of pharmacokinetic investigation. All BPC-157 supplied by NuvoTide is intended exclusively for in-vitro laboratory research.
For in-vitro research use only. Not for human or veterinary use.